Cargando…

Progress in Nanocarriers Codelivery System to Enhance the Anticancer Effect of Photodynamic Therapy

Photodynamic therapy (PDT) is a promising anticancer noninvasive method and has great potential for clinical applications. Unfortunately, PDT still has many limitations, such as metastatic tumor at unknown sites, inadequate light delivery and a lack of sufficient oxygen. Recent studies have demonstr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yu-Ling, Lin, Ke, Yang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617654/
https://www.ncbi.nlm.nih.gov/pubmed/34834367
http://dx.doi.org/10.3390/pharmaceutics13111951
_version_ 1784604557289979904
author Yang, Yu-Ling
Lin, Ke
Yang, Li
author_facet Yang, Yu-Ling
Lin, Ke
Yang, Li
author_sort Yang, Yu-Ling
collection PubMed
description Photodynamic therapy (PDT) is a promising anticancer noninvasive method and has great potential for clinical applications. Unfortunately, PDT still has many limitations, such as metastatic tumor at unknown sites, inadequate light delivery and a lack of sufficient oxygen. Recent studies have demonstrated that photodynamic therapy in combination with other therapies can enhance anticancer effects. The development of new nanomaterials provides a platform for the codelivery of two or more therapeutic drugs, which is a promising cancer treatment method. The use of multifunctional nanocarriers for the codelivery of two or more drugs can improve physical and chemical properties, increase tumor site aggregation, and enhance the antitumor effect through synergistic actions, which is worthy of further study. This review focuses on the latest research progress on the synergistic enhancement of PDT by simultaneous multidrug administration using codelivery nanocarriers. We introduce the design of codelivery nanocarriers and discuss the mechanism of PDT combined with other antitumor methods. The combination of PDT and chemotherapy, gene therapy, immunotherapy, photothermal therapy, hyperthermia, radiotherapy, sonodynamic therapy and even multidrug therapy are discussed to provide a comprehensive understanding.
format Online
Article
Text
id pubmed-8617654
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86176542021-11-27 Progress in Nanocarriers Codelivery System to Enhance the Anticancer Effect of Photodynamic Therapy Yang, Yu-Ling Lin, Ke Yang, Li Pharmaceutics Review Photodynamic therapy (PDT) is a promising anticancer noninvasive method and has great potential for clinical applications. Unfortunately, PDT still has many limitations, such as metastatic tumor at unknown sites, inadequate light delivery and a lack of sufficient oxygen. Recent studies have demonstrated that photodynamic therapy in combination with other therapies can enhance anticancer effects. The development of new nanomaterials provides a platform for the codelivery of two or more therapeutic drugs, which is a promising cancer treatment method. The use of multifunctional nanocarriers for the codelivery of two or more drugs can improve physical and chemical properties, increase tumor site aggregation, and enhance the antitumor effect through synergistic actions, which is worthy of further study. This review focuses on the latest research progress on the synergistic enhancement of PDT by simultaneous multidrug administration using codelivery nanocarriers. We introduce the design of codelivery nanocarriers and discuss the mechanism of PDT combined with other antitumor methods. The combination of PDT and chemotherapy, gene therapy, immunotherapy, photothermal therapy, hyperthermia, radiotherapy, sonodynamic therapy and even multidrug therapy are discussed to provide a comprehensive understanding. MDPI 2021-11-18 /pmc/articles/PMC8617654/ /pubmed/34834367 http://dx.doi.org/10.3390/pharmaceutics13111951 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Yang, Yu-Ling
Lin, Ke
Yang, Li
Progress in Nanocarriers Codelivery System to Enhance the Anticancer Effect of Photodynamic Therapy
title Progress in Nanocarriers Codelivery System to Enhance the Anticancer Effect of Photodynamic Therapy
title_full Progress in Nanocarriers Codelivery System to Enhance the Anticancer Effect of Photodynamic Therapy
title_fullStr Progress in Nanocarriers Codelivery System to Enhance the Anticancer Effect of Photodynamic Therapy
title_full_unstemmed Progress in Nanocarriers Codelivery System to Enhance the Anticancer Effect of Photodynamic Therapy
title_short Progress in Nanocarriers Codelivery System to Enhance the Anticancer Effect of Photodynamic Therapy
title_sort progress in nanocarriers codelivery system to enhance the anticancer effect of photodynamic therapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617654/
https://www.ncbi.nlm.nih.gov/pubmed/34834367
http://dx.doi.org/10.3390/pharmaceutics13111951
work_keys_str_mv AT yangyuling progressinnanocarrierscodeliverysystemtoenhancetheanticancereffectofphotodynamictherapy
AT linke progressinnanocarrierscodeliverysystemtoenhancetheanticancereffectofphotodynamictherapy
AT yangli progressinnanocarrierscodeliverysystemtoenhancetheanticancereffectofphotodynamictherapy